Skip to content
  • Spain
  • United Kingdom
  • United States
  • Japan
  • Arab Emirates
  • Brazil
  • Italy
  • Canada
  • India
  • China
  • Taiwan
  • Mexico
  • Perú
  • Language
  • +91 11 6651 7800 Request Information
  • +91 11 6651 7800 Request Information
IndiaIndia
  • We guide you
    • Fertility
    • Prevent inherited diseases
    • Worry-free pregnancy
  • Our Services
    • For Health Specialists
    • For Patients
  • About us
    • Research & Igenomix Foundation
    • About Igenomix
Our Services > Oncodona

Oncodona

A complete test of genetic screening that analyzes 21 genes related to breast and ovarian cancer.

  • Overview
  • Features
  • How does it Work?
  • I’m a health specialist

Early identification of predisposition to inherited cancer.

Results in 30 days.

Harmful mutations can be transmitted with a 50% probability.

Overview

What is Oncodona test?

  • Oncodona is the most advanced genetic test for early identification of predisposition to inherited cancer.
  • This test analyzes 21 genes related to breast and ovarian cancer in order to locate mutations that increase the risk of developing these types of cancer.
  • Oncodona uses Next Generation Sequencing (NGS) to analyze genetic information present in a panel of 21 genes, including BRCA1 and BRCA2 genes, in order to locate harmful mutations.
Features
  • Indications
  • Benefits

Is Oncodona for you?

This test is recommended if:

  • You’ve been diagnosed with breast cancer and BRCA1 and BRCA2 negative genetic test. Oncodona can find a mutation in up to 4% of women.
  • A woman in your family has been diagnosed with breast and ovarian cancer. 
  • You just want to know if you have any risk of developing breast and ovarian cancer.

Why use Oncodona?

  • The performance of the test, if positive, can be used to adopt follow-up and personalized early detection measures of the patient and their relatives.
  • A negative result means that the patient does not have an increased risk. In other words, their risk of suffering one of the types of cancer analysed by the test is the baseline risk of the population.
How does it work?

BROCHURE

Download
email

Subscribe to
our newsletter

  • *

What now?

  • *

Other services you may be interested

CGT

Carrier Genetic Test
Determines the risk of having a child with a
genetic disease

More information

PGT-M

Prevents the transmission of single gene disorders

More information

PGT-A

Preimplantation Genetic Testing for Aneuploidies
Improves the chances of reproductive success by selecting chromosomally normal embryos

More information

Igenomix is in the media

Talk with friends or family sharing this info

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

OUR SERVICES

Genetic solutions
Learn about genetics

ABOUT US

About Igenomix
Contact
Press and news
Quality
Work with us

FOLLOW IGENOMIX

Blog: Path to fertility

  +91 11 6651 7800
  Write us
  • Spain
  • United Kingdom
  • United States
  • Japan
  • Arab Emirates
  • Brazil
  • Italy
  • Canada
  • India
  • China
  • Taiwan
  • Mexico
  • Perú
Language

[2019] © Igenomix Privacy policy Quality policy Legal note Cookies policy

Request Information

  • *

  • We guide you
    • Fertility
    • Prevent inherited diseases
    • Worry-free pregnancy
  • Our Services
    • For Health Specialists
    • For Patients
  • About us
    • Research & Igenomix Foundation
    • About Igenomix
  • Language